Type 2 diabetes trials in Serbia

1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  Where

  Belgrade, Kamenitz, Kragujevac, Niška Banja, Pančevo

  Age

  18 years and over

  People

  11,800 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07064473 · EU 2025-521188-11-00